RT Book, Section A1 Cohen, David E. A1 Anania, Frank A. A2 Greenberger, Norton J. A2 Blumberg, Richard S. A2 Burakoff, Robert SR Print(0) ID 55961163 T1 Chapter 43. Nonalcoholic Fatty Liver Disease T2 CURRENT Diagnosis & Treatment: Gastroenterology, Hepatology, & Endoscopy, 2e YR 2012 FD 2012 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-176848-1 LK accessmedicine.mhmedical.com/content.aspx?aid=55961163 RD 2024/03/29 AB Nonalcoholic fatty liver disease (NAFLD) is an overarching concept that includes simple steatosis and nonalcoholic steatohepatitis (NASH).NAFLD is commonly associated with the metabolic syndrome, obesity, diabetes, and hyperlipidemia; 80% of patients with the metabolic syndrome have NAFLD.Patients generally present without clinical symptoms but with mild transaminase elevations; NAFLD is the most common cause of increased serum transaminase levels.NAFLD is a clinical diagnosis after exclusion of other causes of liver disease.Ultrasound, computed tomography, and magnetic resonance imaging are useful for the detection.Liver biopsy is currently required to distinguish NASH from NAFLD.